<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">348140</id>
  <title nil="true"/>
  <common-name>(2s)-2-amino-n-[2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]phenyl]-3-phenylpropanamide</common-name>
  <description>(2s)-2-amino-n-[2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]phenyl]-3-phenylpropanamide is a chemical compound with the formula C28H29N3O6. With an average molecular weight of 503.50 g/mol, (2s)-2-amino-n-[2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]phenyl]-3-phenylpropanamide is a heavy molecule.</description>
  <cas nil="true"/>
  <pubchem-id>71503373</pubchem-id>
  <chemical-formula>C28H29N3O6</chemical-formula>
  <weight>503.5</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T12:03:09Z</created-at>
  <updated-at type="dateTime">2026-08-31T12:03:09Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>COC1=C(C=C(C=C1)C2=C(ON=C2)C3=CC(=C(C(=C3)OC)OC)OC)NC(=O)C(CC4=CC=CC=C4)N</moldb-smiles>
  <moldb-formula>C28H29N3O6</moldb-formula>
  <moldb-inchi>InChI=1S/C28H29N3O6/c1-33-23-11-10-18(13-22(23)31-28(32)21(29)12-17-8-6-5-7-9-17)20-16-30-37-26(20)19-14-24(34-2)27(36-4)25(15-19)35-3/h5-11,13-16,21H,12,29H2,1-4H3,(H,31,32)/t21-/m0/s1</moldb-inchi>
  <moldb-inchikey>LHNWLQKEKCACGW-NRFANRHFSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">503.2056357</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>3.8</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM344033</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>(2s)-2-amino-n-[2-methoxy-5-[5-(3,4,5-trimethoxyphenyl)-1,2-oxazol-4-yl]phenyl]-3-phenylpropanamide</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organic acids and derivatives</superklass>
  <klass>Carboxylic acids and derivatives</klass>
  <subklass>Amino acids, peptides, and analogues</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0298475</sync-id>
  <structure-inchikey>LHNWLQKEKCACGW-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>40000000000000000001800200000000000000000040000000000000000000c000000020000000000004000080000020040010000000000000000000000000000000000000000004010000000200000000208000000001000000000000000000000020000100000000440040001080008000000000000000020000000000004000000000602000008000000000000000808010000001000000800000000000000000010040000000100000000800000000000000001000000000000000000005800000000000000100000000000000000000000000000000000002200000000000000080000000400400400008000004000000000000200000000000000a0000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAlAAAAKAAAAIABBgBgAAAAAQMIACgAAAAD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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:46:36Z</structure-indexed-at>
</compound>
